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Synthesis of Highly Functionalized Fluorinated Cispentacin Derivatives
Dedicated to Professor Dieter Seebach on the occasion of his 75th birthday Fluorinated highly functionalized cispentacin derivatives were synthetised starting from an unsaturated bicyclic b-lactam through C¼C bond functionalization via the dipolar cycloaddition of a nitrile oxide, isoxazoline opening, and fluorination by OH/F exchange.
Introduction. -As a result of their biological potential, cyclic b-amino acids are of considerable importance in medicinal chemistry. As conformationally restricted derivatives, they are building blocks for the construction of biologically active peptides [1] [2] . They include cispentacin (1), an important potent antifungal [1a] [1b]. Multisubstituted aminocyclopentanecarboxylic acids such as Peramivir (2) and related analogs 3 (R 1 ¼ H, OH; R 2 ¼ Et, Pr) exhibit strong antiviral properties [3] .
Fluorinated a-and acyclic b-amino acids comprise an expanding area of research, with increasing impact in both chemistry and biochemistry. They are valuable in medicinal chemistry as enzyme inhibitors, antitumour agents, or antibiotics [4] [5] . Only a small number of fluorinated cyclic b-amino acids have been prepared so far, this being particularly true for the five-membered derivatives [6] .
We recently reported the synthesis of highly functionalized cispentacin stereoisomers 7 and 8 from bicyclic b-lactam 4 by means of the regio-and stereoselective 1,3-dipolar cycloaddition of a nitrile oxide (acetonitrile N-oxide) to ethyl cis-and trans-2-aminocyclopentene-3-carboxylates, followed by the stereoselective opening of the isoxazoline ring (Scheme 1) [7] .
tives from bicyclic b-lactam 4 through selective transformation of its C¼C bond by the dipolar cycloaddition of a nitrile oxide, followed by reductive isoxazoline opening and H/F exchange.
Accordingly, novel OH-containing, multifunctionalized b-aminocyclopentanecarboxylates were prepared by reductive ring opening of the isoxazoline skeleton of 9 and 10 [8] (Scheme 2). In contrast to our earlier experiments on Me-substituted compounds (cf. Scheme 1) [7] , the reductive isoxazoline opening of Et-substituted cis-and transisoxazoline-fused derivatives 9 and 10 under similar experimental conditions, with NaBH 4 in the presence of NiCl 2 in EtOH/THF, did not prove to be 100% stereoselective. Both transformations furnished two diastereoisomers, 11 ( Fig. 1) and 12, or 13 and 14, in a ratio of 3 : 1, the major products, 11 and 13, respectively, resulting from H attack on the isoxazoline from the same face of the carbamate (Scheme 2; for several related transformations, see [3] ). The products 11 þ 12 and 13 þ 14 were separated and isolated by column chromatography on SiO 2 .
New multifunctionalized hydroxylated cispentacin analogs containing a longer alkyl chain were next prepared by cycloaddition of the nitrile oxide formed from 2-ethylbutyraldehyde oxime in the presence of N-chlorosuccinimide (NCS; Huisgens conditions) to ethyl cis-and trans-2-aminocyclohexenecarboxylates, 15 and 18, Fig. 1 . a) Molecular structure of compound 11. Only one of two similar molecules in the asymmetric unit is presented. b) Ball-and-stick model of 11 showing inter-and intramolecular H-bonds. Thermal ellipsoids have been drawn at 30% probability level, and the CÀH H-atoms are omitted for clarity.
conditions were found under which the large amounts of elimination products could be avoided. Under similar conditions, fluorination of the trans counterparts 8, 13, and 22 provided the required fluorinated products 26a and 26b, unfortunately again together with large quantities of elimination products 27a -27c, respectively (Scheme 6).
To summarize, highly functionalized fluorinated b-aminocyclopentanecarboxylate regio-and stereoisomers containing multiple stereogenic centers were synthesized from b-aminocyclopentenecarboxylates through the 1,3-dipolar cycloaddition of nitrile oxides and reductive ring opening of the isoxazoline skeleton, followed by H/F exchange. These products may be regarded not only as fluorinated cispentacin derivatives, but as precursors for the preparation of b-amino acid-modified peramivir analogs.
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Scheme 5
Experimental Part
General. The chemicals were purchased from Aldrich. Synthesis of 2-Ethylbutyraldehyde Oxime ( ¼ (1E)-2-Ethyl-N-hydroxybutan-1-imine). To a soln. of 2-ethylbutyraldehyde ( ¼ 2-ethylbutanal; 50 mmol) in EtOH (50 ml), dry pyridine (150 mmol), and NH 2 OH · HCl (50 mmol) were added, and the mixture was stirred under reflux for 7 h. The mixture was then concentrated under reduced pressure, and the crude residue was purified by column chromatography (CC) on SiO 2 (hexane/AcOEt) to give (1E)-2-ethyl-N-hydroxybutan-1-imine.
General Procedure for the Synthesis of Isoxazoline-Fused b-Aminocyclopentanecarboxylates. To a soln. of amino ester 15 or 18 (19.6 mmol) in THF (70 ml), (1E)-2-ethyl-N-hydroxybutan-1-imine (118 mmol) , Et 2 NH (19.6 mmol) , and N-chlorosuccinimide ( ¼ 1-chloropyrrolidine-2,5-dione ; 78.4 mmol) were added, and the mixture was stirred at r.t. for 48 h. The mixture was then diluted with AcOEt (75 ml), washed with H 2 O (3Â 20 ml), dried (Na 2 SO 4 ), and concentrated under reduced pressure. The crude mixture was purified by CC (SiO 2 ; hexane/AcOEt to give 16/17 and 19).
General Procedure for Isoxazoline Ring Opening. To a soln. of dihydroisoxazol 9, 10, 16, or 19 (1.46 mmol) in 10 ml of EtOH/THF 3 : 1 (v/v), NiCl 2 (2.92 mmol) and Boc 2 O (2.92 mmol) were added. After stirring for 10 min, NaBH 4 (2.92 mmol) was added in portions. The mixture was stirred at r.t. for 5 h, and the reaction was then quenched by the addition of H 2 O (5 ml). The mixture was filtered through Celite pad, and the filtrate was concentrated under reduced pressure. The residue was diluted with AcOEt (30 ml), washed with H 2 O (3Â 10 ml), dried (Na 2 SO 4 ), and evaporated in vacuo. The products 11/12, 13/14, 20/21, and 22/23 were purified and separated by CC (SiO 2 ; hexane/AcOEt).
General Procedure for the Synthesis of F-Containing b-Aminocyclopentanecarboxylates. To a soln. of hydroxy compounds 7, 8, 11, 13, 20, or 22 (0.5 mmol) in dry toluene (10 ml), Deoxo-Fluor soln. (50% in toluene, 0.6 mmol) was added at 08 under Ar. The mixture was stirred at 08 for 2 h, and the mixture was then diluted with AcOEt, washed with sat. NaHCO 3 soln. (3 Â 10 ml), followed by H 2 O (2Â 10 ml), dried (Na 2 SO 4 ), and concentrated under reduced pressure. The crude residue was purified by CC (SiO 2 ; hexane/AcOEt)to furnish 24a -24c, 25a -25c, 26a and 26b, and 27a -27c. 10.9; 13.7; 27.9; 28.0; 28.4; 36.4; 43.8; 50.1; 50.3; 53.8; 60.3; 72.9; 79.3; 79.6; 155.2; 157.3; 174.9 10.0; 13.8; 25.3; 27.9; 35.4; 45.6; 50.9; 51.9; 56.6; 60.2; 71.3; 78.9; 79.5; 154.4; 156.7; 174 (4)); HÀC(6a) , NH).
13
C-NMR (100 MHz, CDCl 3 ): 11.4; 12.5; 14.5; 24.4; 25.9; 28.6; 31.6; 36.9; 41.0; 45.6; 52.1; 57.1; 61.6; 62.9; 83.7; 155.4; 160.8 (5) C-NMR (100 MHz, CDCl 3 ): 10.5; 11.2; 14.5; 23.9; 26.2; 30.0; 31.4; 35.9; 42.1; 44.9; 52.2; 56.9; 59.6; 62.9; 85.0; 155.4; 161.4 11.0; 12.0; 14.3; 21.0; 24.3; 26.2; 27.0; 28.4; 44.3; 45.4; 48.0; 51.6; 58.8; 63.0; 73.8; 80.0; 127.0; 142.0; 153.7; 158 11.5; 11.9; 13.7; 21.2; 22.6; 25.2; 27.9; 27.9; 44.3; 44.7; 46.3; 50.9; 58.8; 60.3; 74.2; 79.1; 126.9; 142.0; 154.9; 156.3 (4), HÀC (2)); 5.58 -5.67 (br. s, NH).
C-NMR (100 MHz, CDCl 3 ): 14. 5; 19.6; 28.8; 34.8; 34.9; 45.2; 46.1; 52.2; 55.9; 56.1; 61.3; 79.1; 79.8; 95.9; 152.8; 173.5 (2)); 5.65 (s, HÀC (4)).
C-NMR (100 MHz, CDCl 3 ): 14.6; 21. 2; 28.7; 28.8; 33.3; 45.7; 47.7; 57.4; 61.0; 79.9; 121.4; 126.2; 155.5; 158.5; 172.9 C-NMR (100 MHz, CDCl 3 ): 10.5; 13.6; 26.4; 27.9; 34.1; 44.5; 50.9; 51.3; 54.0; 60.5; 78.8; 79.3; 94.5; 95.9; 155.0; 155.9; 173. (4)). 13 C-NMR (100 MHz, CDCl 3 ): 9.6; 13.8; 26.6; 27.9; 27.9; 32.5; 46.7; 56.6; 60.2; 79.1; 112.5; 115.4; 117.2; 126.4; 154.8; 171.3; (3)) ; CH); HÀC(2) , CH 2 O); 4.82 (br. s, NH); HÀC(4) ); 5.68 -5.79 (br. s, NH).
C-NMR (100 MHz, CDCl 3 ): 9.5; 10.3; 13.6; 20.8; 21.4; 27.9; 34.0; 41.9; 44.7; 51.1; 51.2; 51.5; 60.5; 78.7; 79.2; 95.3; 96.7; 154.9; 156.0; þ ). Anal. calc. for C 24 H 43 FN 2 O 6 : C 60.74, H 9.13, N 5.90; found: C 60.73, H 9.12, N 5.92 . (2)); HÀC(4) ).
13 C-NMR (100 MHz, CDCl 3 ): 11.2; 12.2; 13.8; 21.1; 22.2; 27.8; 27.9; 32.4; 42.4; 46.7; 50.3; 56.5; 60.1; 78.8; 78.9; 126.5; 143.1; 154.6; 155.2; 172 (2)); NH); NH, HÀC(3) ).
C-NMR (100 MHz, CDCl 3 ): 13. 7; 15.5; 27.9; 33.5; 36.6; 46.5; 48.1; 50.8; 51.5; 51.7; 60.6; 79.2; 103.6; 105.0; 154.8; 172.6 (3)).
C-NMR (100 MHz, CDCl 3 ): 13. 7; 19.4; 27.9; 36.77; 44.9; 46.7; 46.6; 50.7; 60.4; 78.0; 79.2; 124.7; 148.3; 154.7; 167.8 9.9; 13.7; 22.7; 27.9; 36.8; 47.9; 49.7; 52.9; 53.7; 57.3; 57.5; 60.5; 79.1; 103.8; 105.2; 154.3; 155.8 (3)).
C-NMR (100 MHz, CDCl 3 ): 9.8; 13.7; 22.6; 26.1; 27.9; 50.6; 51.5; 57.3; 60.5; 79.0; 103.8; 105.2; 124.6; 154.6; 155.8; 172.7 (3)).
C-NMR (100 MHz, CDCl 3 ): 10.8; 11.2; 13.7; 21.5; 22.6; 27.8; 27.9; 34.4; 43.1; 50.2; 52.0; 57.11; 60.4; 78.5; 79.1; 103.2; 105.5; 153.9; 155.8; 171.7 H 9.31, N 6.16; found: C 63.44, H 9.30 , N 6.14. X-Rray Crystallographic Studies. Crystallographic data for the compounds 11 and 20 were collected with Agilent Supernova diffractometer equipped with Atlas area detector using CuK a radiation (l ¼ 1.54184 ). Empirical absorption correction, using spherical harmonics implemented in SCALE3 ABSPACK scaling algorithm, was applied for both compounds with CrysAlisPro program package [9] . The structures were solved by direct methods using SIR97 [10] program, and full-matrix, least-squares refinements on F 2 were performed using the SHELXL-97 [11] program. Molecular structure figures were drawn with Diamond3 program [12] . Selected crystallographic data collected in CCDC-902350 and -902351 contain the supplementary crystallographic data for 11 and 20. These data can be obtained free of charge via ttp://www.ccdc.cam.ac.uk/conts/retrieving.html, or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: ( þ 44) 1223-336-033; or e-mail: deposit@ccdc. cam.ac.uk.
